MLEC
Moolec Science SA
NASDAQ · Healthcare · Biotechnology · LU
$6.10
−2.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 1.02x
- P/E 2028E
- 0.20x
- P/S forward
- 4.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.54x
- Price / sales
- 0.04x
- Price / cash flow
- -0.52x
Enterprise value
- Enterprise value
- $32.8M
- EV / sales
- 0.10x
- EV / EBITDA
- -0.48x
- EV / EBIT
- -3.13x
- Market cap
- $12.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2025